Using graph networks to identify microbiome-based therapeutics for neurodegenerative diseases

Neurodegenerative diseases such as Parkinson's disease, Motor Neuron Disease, or dementia, are the leading cause of global disability yet there are no interventions that can alter the steady progression of the disease, dampen its severity, or prevent it. The human gut microbiome has come into focus as a potential mechanism and thereby target for…